Bioptik Technology Incorporation Balance Sheet Health
Financial Health criteria checks 6/6
Bioptik Technology Incorporation has a total shareholder equity of NT$824.2M and total debt of NT$463.6M, which brings its debt-to-equity ratio to 56.3%. Its total assets and total liabilities are NT$1.5B and NT$673.6M respectively. Bioptik Technology Incorporation's EBIT is NT$90.0M making its interest coverage ratio 302.9. It has cash and short-term investments of NT$394.1M.
Key information
56.3%
Debt to equity ratio
NT$463.61m
Debt
| Interest coverage ratio | 302.9x |
| Cash | NT$394.13m |
| Equity | NT$824.15m |
| Total liabilities | NT$673.56m |
| Total assets | NT$1.50b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 4161's short term assets (NT$872.2M) exceed its short term liabilities (NT$516.8M).
Long Term Liabilities: 4161's short term assets (NT$872.2M) exceed its long term liabilities (NT$156.8M).
Debt to Equity History and Analysis
Debt Level: 4161's net debt to equity ratio (8.4%) is considered satisfactory.
Reducing Debt: 4161's debt to equity ratio has reduced from 80.7% to 56.3% over the past 5 years.
Debt Coverage: 4161's debt is well covered by operating cash flow (44.4%).
Interest Coverage: 4161's interest payments on its debt are well covered by EBIT (302.9x coverage).